Medicared For All Logo

Mahmoud Mahafzah MD in Oak Lawn, Illinois

Home Illinois Oak Lawn

Mahmoud Mahafzah MD has Hematology/oncology as his primary medical specialty. Their primary office is: 4440 W 95th St in Oak Lawn, Illinois.

They're a part of the: Affiliated Oncologists Llc medical group which has around 38 members. You can call their office at 708-684-5475 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1979 (around 45 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mahmoud K Mahafzah MD Office Phone and Directions

Mahmoud Mahafzah MD
Affiliated Oncologists Llc
4440 W 95th St
Oak Lawn, Illinois 60453
708-684-5475

Patient Ratings
Please rate your experience with Mahmoud Mahafzah MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 708-684-5475


Enter a starting address:


Healthcare Info for Mahmoud Mahafzah MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1979
The Primary Medical Specialty for Mahmoud Mahafzah MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 45
PAC (PECOS ID)#: 4183668940
NPI #: 1134148091
NPI Created On: 07/19/2006
NPI Last Updated Listed as: 07/26/2019
Primary Taxonomy Code: 207RH0003X
License Number:
036091528
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic, Spanish.

Services and Procedures include:

  1. Nuclear medicine study with ct imaging skull base to mid-thigh
  2. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  4. Infusion of chemotherapy into a vein up to 1 hour
  5. Established patient office or other outpatient visit, typically 15 minutes
  6. Established patient office or other outpatient, visit typically 25 minutes
  7. Established patient office or other outpatient, visit typically 40 minutes
  8. Initial hospital inpatient care, typically 70 minutes per day
  9. Subsequent hospital inpatient care, typically 25 minutes per day
  10. Subsequent hospital inpatient care, typically 35 minutes per day
  11. Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
  12. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
  13. Injection, denosumab, 1 mg
  14. Injection, dexamethasone sodium phosphate, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787897793

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012541

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818630909

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $106

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818632529

Being Disputed:: No

Product Related: Yes

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818646197

Being Disputed:: No

Product Related: No

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802409791

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832152641

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832152739

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783730223

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783730221

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: Revlimid

Open Associated Drug #1: 59572-405-28

Hematology/oncology Professionals in Oak Lawn

1.
Marie Ellen Sarvida

4440 W 95th St
Oak-lawn, IL
Advocate Health And Hospitals Corporation

2.
Mouhammed Kelta

4440 W 95th St
Oak-lawn, IL
Affiliated Oncologists Llc

3.
Rajalaxmi Mckenna MD

10458 S Pulaski Rd
Oak-lawn, IL
Southwest Medical Consultants Sc

4.
Syed Huq

4440 W 95th St
Oak-lawn, IL
Advocate Health And Hospitals Corporation

5.
Subramanya Rao

4440 W 95th St
Oak-lawn, IL
Affiliated Oncologists Llc

6.
Rupa Chennamaneni MD

4440 W 95th St
Oak-lawn, IL
Advocate Health And Hospitals Corporation

Providers in Affiliated Oncologists Llc

1.Vasia Ahmed Md

10604 Southwest Hwy
Chicago Ridge Il 60415-1429
Affiliated Oncologists Llc
Hematology/oncology

2.Elke Aippersbach

4301 W 95th St
Oak Lawn Il 60453-2670
Affiliated Oncologists Llc
Radiation Oncology

3.Rasheed Akhtar

19060 Everett Blvd
Mokena Il 60448-1942
Affiliated Oncologists Llc
Internal Medicine

4.Jennifer Bednarz

10604 Southwest Hwy
Chicago Ridge Il 60415-1429
Affiliated Oncologists Llc
Nurse Practitioner

5.Jennifer Bednarz

19060 Everett Blvd
Mokena Il 60448-1942
Affiliated Oncologists Llc
Nurse Practitioner

6.Monika Benner

10604 Southwest Hwy
Chicago Ridge Il 60415-1429
Affiliated Oncologists Llc
Nurse Practitioner

View all 38 members of Affiliated Oncologists Llc medical group


Medicared For All
Vote!
Share